WebOct 5, 2009 · Giving radiotherapy a boost. Until a few years ago, little research was done in radiotherapy since, unlike drug trials (often bankrolled by pharmaceutical companies) there was little financial incentive. But alongside technical advances, the UK cancer community recognised the importance of researching radiotherapy – and the need to do even more. WebNational Center for Biotechnology Information
Stereotactic Ablative Radiotherapy for the Comprehensive …
WebJun 2, 2024 · Other phase II trials have suggested benefits of ablative therapies in the setting of colorectal cancer liver metastases, 21,22 in non–small-cell lung cancer (NSCLC), 13,15,17 and in prostate cancer. 16,18 As a notable exception, the PulMiCC phase III trial failed to show a benefit for surgical resection of pulmonary metastases from colorectal … WebMar 31, 2024 · Age ≥60 (or ,60, postmenopausal and comorbidities implying high risk of radiotherapy toxicity ) Breast conserving surgery with complete resection of tumour … mha number 7 hero
Can patient decision aids reduce decisional conflict in a de ... - Trials
WebSep 2, 2024 · Abstract. Radiotherapy has proven efficacy in a wide range of cancers. There is growing interest in evaluating radiotherapy–novel agent combinations and a drive to initiate this earlier in the clinical development of the novel agent, where the scientific rationale and preclinical evidence for a radiotherapy combination approach are high. … WebApr 25, 2015 · Though the use of external-beam radiotherapy specifically went down from 66% to 54% (P < .001), an unexpected and fascinating finding was a simultaneous increase in implant-based radiotherapy from 1.4% to 6.2%, which diminished the overall effect of omitting radiation in these low-risk elderly patients. 7. Reasons for Slow Adoption WebJun 14, 2024 · PRIMETIME (ISRCTN 41579286) is a UK-led biomarker-directed study evaluating omission of adjuvant radiotherapy in breast cancer; an embedded Study Within A Trial (SWAT) investigated whether PDA ... mhany store